Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Alzheimer Disease

Texas researchers receive $149 million for large study of Alzheimer’s in racial, ethnic groups

FORT WORTH, Texas — The National Institutes of Health is giving $149 million to researchers at the University of North Texas Health Science Center to pay for researchers to study the biology of Alzheimer’s disease in multiple racial and ethnic groups.

Tribune News Service

Alzheimer's risk increased by 80% in over 65s who have had Covid, claims study

Experts are still unclear as to whether Covid can trigger the onset of Alzheimer's or speed its development.

Daily Record

Over-65s twice as likely to develop Alzheimer’s within a year of Covid infection, according to study

Researchers from the Case Western Reserve University in Cleveland, Ohio analysed the electronic health records of 6.2 million adults

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Covid warning to everyone aged 66 and above

New research has found over 65s who contract covid increase their risk of getting Alzheimer's

Liverpool Echo

Having had Covid can increase risk of Alzheimer's by 80% for some people

Researchers aren't certain whether COVID-19 triggers new development of Alzheimer’s disease or accelerates its emergence

Wales Online

Over-65s who had Covid are 80 per cent more likely to develop Alzheimer’s, study reveals

It is unclear whether coronavirus triggers new development of the disease or accelerates its emergence

The Independent UK

‘Historic moment’: Drug slows cognitive decline in Alzheimer’s

It's being widely reported that an experimental drug has slowed the cognitive decline and brain damage in Alzheimer's patients.

The New Daily

Read news from The Economist, FT, and more,
with one subscription

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win

Eli Lilly And Co (NYSE:LLY) - Market cap: $295 billion.

Benzinga

Drug shown to slow memory decline in Alzheimer's patients in 'historic' breakthrough

Alzheimer's Research UK said this is the first later-stage trial of an Alzheimer's drug 'in a generation' to successfully slow cognitive decline

Wales Online

Alzheimer's drug is world's first shown to slow symptoms in 'historic' breakthrough

The success of an experimental drug offers new hope to people affected by the cruel disease.

Daily Record

‘Historic’ breakthrough as dementia drug shown to slow cognitive decline

Lecanemab found to slow decline in participants’ memory and thinking caused by the brain-wasting disease by 27 per cent

Evening Standard

World's first EVER drug shown to work against Alzheimer's developed by scientists

Scientists say the development of the only drug to work against Alzheimer’s is a 'historic moment' - with regulators expected to approve the groundbreaking drug by the New Year

Daily Mirror

Major breakthrough for dementia and Alzheimer's as drug found to reduce decline

Alzheimer’s Research UK said the finding was a “historic moment for dementia research”

Wales Online

‘Major breakthrough’ as dementia drug found to ‘slow cognitive decline’

The new clinical trial found that there was a significant reduction in the decline in memory and thinking usually seen in early-stage patients.

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Dynamite News

Health: Study finds Alzheimer's disease risk connected to newly discovered protein

According to a new USC study, a mutation in a newly discovered small protein is connected to a significant increase in the risk for Alzheimer's disease, expanding the known gene targets for the disease and presenting a new potential avenue for treatment. Read more on Dynamite News:

Daily Record

The simple steps to help prevent Alzheimer's and keep your brain active and healthy

Here's some helpful advice if you are worried about dementia or are supporting a loved one who is suffering.

Benzinga

IGC Announces Issuance Of Second Patent For The Treatment Of Alzheimer's Using THC

India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer’s disease.”

The Conversation

Alzheimer’s might not be primarily a brain disease. A new theory suggests it’s an autoimmune condition.

The pursuit of a cure for Alzheimer’s disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Daily multi-vitamins may improve brain function in older people – US study

Trial finds supplements could slow decline by 60% but Alzheimer’s and dementia experts caution larger studies needed

WEKU

With early Alzheimer's in the family, these sisters decided to test for the gene

For some people, a rare genetic mutation makes dementia inescapable. Three sisters have decided to confront fate with a genetic test and have joined a research project on possible treatments.

The Independent UK

People with ‘poor dental hygiene’ more likely to develop Alzheimer’s, study finds

There is currently no cure for the progressive condition

Wales Online

Signs of Alzheimer's disease to look out for including mood swings, weight loss and sleep problems

Alzheimer's disease is the most common form of dementia and the signs differ as it develops

Liverpool Echo

Alzheimer's Disease signs to look out for

Alzheimer's disease is the most common form of dementia

The Conversation

A window to the brain: the retina gives away signs of Alzheimer's disease and could help with early detection

The retina has long been poeticised as the window to the soul, but research now shows it could be a window to the brain and act as an early warning system for cognitive decline.

Inverse

Mice models for studying Alzheimer’s disease aren’t enough — here’s what will help

A more complementary animal model, however, could help researchers better translate the results from animal studies to humans.

1 … 10 11 12 13

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University College London

185 stories

USF

184 stories

Alzheimer Research UK

149 stories

National Institutes of Health

Alzheimer Association

19 stories

Wake Forest University

18 stories

Case Western Reserve University

16 stories

IGC

16 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.